Researchers inhibited NFAT1 by the inhibitory peptide 11R-VIVIT in a mouse model of synucleinopathy and demonstrated that NFAT1 inhibition reduced neurodegeneration, neuroinflammation and α-synuclein neuropathology. Here, NFATC2 is linked to synucleinopathy.